Sambati V, Laudisio S, Motta M, Esposito S
Int J Mol Sci. 2024; 25(20).
PMID: 39456788
PMC: 11508002.
DOI: 10.3390/ijms252011006.
O A, Akhila B, George S
J Fluoresc. 2024; .
PMID: 38865062
DOI: 10.1007/s10895-024-03771-0.
He T, Geng X, Zhu L, Lin X, Wang L
Front Med (Lausanne). 2024; 11:1354514.
PMID: 38784231
PMC: 11112071.
DOI: 10.3389/fmed.2024.1354514.
Paul B, Pieper A
Biomolecules. 2024; 14(2).
PMID: 38397392
PMC: 10887292.
DOI: 10.3390/biom14020155.
Nulty J, Anand H, Dhawan A
Stem Cells Transl Med. 2023; 13(3):204-218.
PMID: 38103170
PMC: 10940836.
DOI: 10.1093/stcltm/szad084.
CRISPR-Cas9-mediated somatic correction of a one-base deletion in the Ugt1a gene ameliorates hyperbilirubinemia in Crigler-Najjar syndrome mice.
Bortolussi G, Iaconcig A, Canarutto G, Porro F, Ferrucci F, Galletta C
Mol Ther Methods Clin Dev. 2023; 31:101161.
PMID: 38094199
PMC: 10716028.
DOI: 10.1016/j.omtm.2023.101161.
Case report: Crigler-Najjar syndrome type 1 in Croatia-more than a one in a million: a case series.
Kovacic Perica M, Todoric I, Marcinkovic N, Dzepina P, Anicic M, Mrzljak A
Front Pediatr. 2023; 11:1276349.
PMID: 37928349
PMC: 10620791.
DOI: 10.3389/fped.2023.1276349.
Lipid nanoparticle-encapsulated mRNA therapy corrects serum total bilirubin level in Crigler-Najjar syndrome mouse model.
Greig J, Chorazeczewski J, Chowdhary V, Smith M, Jennis M, Tarrant J
Mol Ther Methods Clin Dev. 2023; 29:32-39.
PMID: 36936447
PMC: 10017950.
DOI: 10.1016/j.omtm.2023.02.007.
Various AAV Serotypes and Their Applications in Gene Therapy: An Overview.
Issa S, Shaimardanova A, Solovyeva V, Rizvanov A
Cells. 2023; 12(5).
PMID: 36899921
PMC: 10000783.
DOI: 10.3390/cells12050785.
Bilirubin-Induced Neurological Damage: Current and Emerging iPSC-Derived Brain Organoid Models.
Pranty A, Shumka S, Adjaye J
Cells. 2022; 11(17).
PMID: 36078055
PMC: 9454749.
DOI: 10.3390/cells11172647.
Novel combined UGT1A1 mutations in Crigler Najjar Syndrome type I.
Abdellaoui N, Abdelmoula B, Abdelhedi R, Kharrat N, Tabebi M, Rebai A
J Clin Lab Anal. 2022; 36(6):e24482.
PMID: 35527687
PMC: 9169181.
DOI: 10.1002/jcla.24482.
Pharmaceutical strategies for preventing toxicity and promoting antioxidant and anti-inflammatory actions of bilirubin.
Nocentini A, Bonardi A, Pratesi S, Gratteri P, Dani C, Supuran C
J Enzyme Inhib Med Chem. 2022; 37(1):487-501.
PMID: 34986721
PMC: 8741241.
DOI: 10.1080/14756366.2021.2020773.
Management of Crigler-Najjar syndrome.
Tcaciuc E, Podurean M, Tcaciuc A
Med Pharm Rep. 2021; 94(Suppl No 1):S64-S67.
PMID: 34527915
PMC: 8411811.
DOI: 10.15386/mpr-2234.
A Fast and Effective System for Detection of Neonatal Jaundice with a Dynamic Threshold White Balance Algorithm.
Hsu W, Cheng H
Healthcare (Basel). 2021; 9(8).
PMID: 34442190
PMC: 8394022.
DOI: 10.3390/healthcare9081052.
-related Bilirubin Encephalopathy/Kernicterus in Adults.
Bai J, Li L, Liu H, Liu S, Bai L, Song W
J Clin Transl Hepatol. 2021; 9(2):180-186.
PMID: 34007799
PMC: 8111108.
DOI: 10.14218/JCTH.2020.00108.
The First Two Liver Transplantations in Syria.
Rayya F
Case Rep Gastroenterol. 2021; 15(1):296-304.
PMID: 33790718
PMC: 7989781.
DOI: 10.1159/000513281.
Efficacy of AAV8-h with Rapamycin in neonatal, suckling, and juvenile rats to model treatment in pediatric CNs patients.
Shi X, Aronson S, Bloemendaal L, Duijst S, Bakker R, de Waart D
Mol Ther Methods Clin Dev. 2021; 20:287-297.
PMID: 33511243
PMC: 7809245.
DOI: 10.1016/j.omtm.2020.11.016.
A Quantitative Potency Assay for Adeno-Associated Virus Vectors Encoding for the Transgene.
Aronson S, Bakker R, Moenis S, van Dijk R, Bortolussi G, Collaud F
Mol Ther Methods Clin Dev. 2020; 18:250-258.
PMID: 32637454
PMC: 7327880.
DOI: 10.1016/j.omtm.2020.06.002.
Human liver stem cells express UGT1A1 and improve phenotype of immunocompromised Crigler Najjar syndrome type I mice.
Famulari E, Navarro-Tableros V, Herrera Sanchez M, Bortolussi G, Gai M, Conti L
Sci Rep. 2020; 10(1):887.
PMID: 31965023
PMC: 6972964.
DOI: 10.1038/s41598-020-57820-2.
Crigler-Najjar Syndrome Type 1: Pathophysiology, Natural History, and Therapeutic Frontier.
Strauss K, Ahlfors C, Soltys K, Mazareigos G, Young M, Bowser L
Hepatology. 2019; 71(6):1923-1939.
PMID: 31553814
PMC: 7909716.
DOI: 10.1002/hep.30959.
